Skip to Content
Merck
All Photos(1)

Key Documents

SML1210

Sigma-Aldrich

Almotriptan malate

≥98% (HPLC)

Synonym(s):

3-[2-(Dimethylamino)ethyl]-5-(pyrrolidin-1-ylsulfonylmethyl )-1H-indole malate, PNU 180638

Sign Into View Organizational & Contract Pricing

Select a Size

10 MG
€156.00
50 MG
€600.00

€156.00

Please contact Customer Service for Availability
All Photos(1)

Select a Size

Change View
10 MG
€156.00
50 MG
€600.00

About This Item

Empirical Formula (Hill Notation):
C17H25N3O2S · C4H6O5
CAS Number:
181183-52-8
Molecular Weight:
469.55
UNSPSC Code:
12352200
NACRES:
NA.77

€156.00

Please contact Customer Service for Availability

Quality Level

100

Assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

H2O: 10 mg/mL, clear

storage temp.

−20°C

SMILES string

[S](=O)(=O)(N3CCCC3)Cc1cc2c([nH]cc2CCN(C)C)cc1.OC(CC(=O)O)C(=O)O

InChI

1S/C17H25N3O2S.C4H6O5/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20;5-2(4(8)9)1-3(6)7/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3;2,5H,1H2,(H,6,7)(H,8,9)

InChI key

QHATUKWEVNMHRY-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

Almotriptan at an oral dose of 12.5 mg, is recommended to be safe for treating migraine.[1][2]
Almotriptan is a serotonin 5HT-1B/1D-receptor agonist; antimigraine.

Biochem/physiol Actions

Almotriptan is a serotonin 5HT-1B/1D-receptor agonist used to treat migraine. Almotriptan has low nanomolar affinity for the 5-HT(1B) and 5-HT(1D) receptors while affinity for 5-HT receptors other than 5-HT(1B/1D) is substantially lower. Affinity for 5-HT(7) and 5-HT(1A) receptors was approximately 40 and 60 times lower than that for 5-HT(1B/1D) receptors, respectively.
Almotriptan is a serotonin 5HT-1B/1D-receptor agonist; antimigraine.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000406424
0000406424
015M4733V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Dose finding, placebo-controlled study of oral almotriptan in the acute treatment of migraine
Dahlof C, et al.
Neurology, 57(10), 1811-1817 (2001)
Kremena Saracheva et al.
Acta pharmaceutica (Zagreb, Croatia), 70(2), 239-247 (2020-01-20)
The introduction of the second generation triptans in clinical and experimental practice was a major progress in the pharmacotherapy of migraine. Frovatriptan is a second generation triptan with strong 5-HT1B/1D serotonergic agonism and low 5-HT1A/7 receptor affinity, while almotriptan possesses
Long?term Efficacy and Safety of Oral Almotriptan: Interim Analysis of a 1?Year Open Study
Cabarrocas X, et al.
Headache, 41(1), 57-62 (2001)
Barbora Vyhlídalová et al.
International journal of molecular sciences, 21(8) (2020-04-23)
The efforts for therapeutic targeting of the aryl hydrocarbon receptor (AhR) have emerged in recent years. We investigated the effects of available antimigraine triptan drugs, having an indole core in their structure, on AhR signaling in human hepatic and intestinal

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service